• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Klaria Pharma Holding

0.80 SEK

-3.38 %

Less than 1K followers

KLAR

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-3.38 %
-0.99 %
+0.12 %
+20.27 %
+40.53 %
+95.65 %
+77.86 %
-90.51 %
-82.47 %

Klaria Pharma Holding operates in the pharmaceutical industry. The business is focused on developing and commercializing solutions in the therapeutic areas of migraine and cancer-related pain. The technology is based on the company's drug-delivery platform, where the product consists of an alginate-based polymer film. The film is attached to the patient's oral mucosa, which enables the distribution of drugs in the body. The headquarters are located in Uppsala.

Read more
Market cap
197.03M SEK
Turnover
1.63M SEK
Revenue
8.99M
EBIT %
-280.72 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
27.8
2026

Interim report Q2'26

26.11
2026

Interim report Q3'26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release6/5/2026, 8:48 PM

Klaria Pharma Holding AB: Klaria Annual Report 2025

Klaria Pharma Holding
Regulatory press release6/5/2026, 6:13 PM

Klaria Pharma Holding AB: Klaria receives 25 MSEK in loan financing with the possibility of an additional 15 MSEK

Klaria Pharma Holding
Regulatory press release5/29/2026, 11:28 AM

Klaria Pharma Holding AB: Klaria Interim Report Q1 2026

Klaria Pharma Holding

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/28/2026, 6:35 AM

Klaria Pharma Holding AB: Klaria adjusts annual report release date

Klaria Pharma Holding
Regulatory press release5/25/2026, 10:51 AM

Summons to the Annual General Meeting of Klaria Pharma Holding AB (publ)

Klaria Pharma Holding
Regulatory press release5/22/2026, 10:01 AM

Klaria Pharma Holding AB: Klaria postpones interim Q1 report

Klaria Pharma Holding
Regulatory press release5/21/2026, 7:09 PM

Klaria Pharma Holding AB: Klaria postpones publication of the annual report

Klaria Pharma Holding
Regulatory press release4/23/2026, 7:56 AM

Notice of the Annual General Meeting of Klaria Pharma Holding AB (publ)

Klaria Pharma Holding
Regulatory press release4/5/2026, 2:56 PM

Klaria Pharma Holding AB: Annula Genernal Meeting Date Change:  Klaria Pharma Holding (publ)

Klaria Pharma Holding
Regulatory press release3/19/2026, 7:41 PM

Correction: Incorrect inclusion of MAR text in earlier release.Summary of extraordinary general meeting in Klaria Pharma Holding AB (publ)

Klaria Pharma Holding
Regulatory press release3/19/2026, 3:16 PM

Summary of extraordinary general meeting in Klaria Pharma Holding AB (publ)

Klaria Pharma Holding
Regulatory press release3/2/2026, 12:33 PM

Klaria Pharma Holding AB (publ) Summons to Extraordinary General Meeting

Klaria Pharma Holding
Regulatory press release2/20/2026, 3:00 PM

Klaria Pharma Holding AB: Klaria Year-End Report

Klaria Pharma Holding
Regulatory press release12/23/2025, 1:21 PM

Klaria Pharma Holding AB: Klaria accelerates its business development work in collaboration with BDO

Klaria Pharma Holding
Regulatory press release12/17/2025, 12:24 PM

Klaria Pharma Holding AB: Klaria Receives Positive Opinion on Sumatriptan Oral Film Patent Application

Klaria Pharma Holding
Regulatory press release11/26/2025, 4:00 PM

Klaria Pharma Holding AB: Klaria Interim Report Q3 2025

Klaria Pharma Holding
Regulatory press release8/28/2025, 6:30 AM

Klaria Pharma Holding AB: Klaria Interim Report Q2 2025

Klaria Pharma Holding
Regulatory press release7/3/2025, 8:30 AM

Klaria Pharma Holding AB: Klaria stengthens patent portfolio of sumatriptan alginate film with new filing

Klaria Pharma Holding
Regulatory press release5/21/2025, 2:16 PM

Klaria Pharma Holding AB: Klaria Interim Report

Klaria Pharma Holding
Regulatory press release4/30/2025, 9:00 AM

Klaria Pharma Holding AB: Klaria Annual Report 2024

Klaria Pharma Holding